• -€1.20
  • - €1.20

Fluimucil Mucolytic Syrup Bottle 200 ml

€12.00
€10.80 Risparmio €1.20
Tax included
Minsan
034936118
100% secure payments
Sorry, no items left.
Quantity
Out-of-Stock

WARNINGS
Patients with bronchial asthma must be closely monitored during therapy, if bronchospasm occurs, the treatment must be stopped immediately. Mucolytics can induce bronchial obstruction in children younger 'less than 2 years. In fact, the drainage capacity of the bronchial mucus is limited in this age group, due to the physiological characteristics of the respiratory tract. They should therefore not be used in children younger 'less than 2 years. The use of the medicinal product in patients suffering from peptic ulcer or with a history of peptic ulcer, especially in the case of concomitant use of other drugs with a known gastric-damaging effect, requires particular attention. In the case of diabetic subjects or those who follow low-calorie diets it should be borne in mind that the preparation in sachets contains sugar. In these cases it is possible to use the packet in sugar-free sachets. The possible presence of a sulphurous odor does not indicate alteration of the preparation but is proper to the active ingredient contained therein. The administration of N-acetylcysteine, especially at the beginning of the treatment, can thin the bronchial secretions and at the same time increase their volume. If the patient is unable to expectorate effectively, postural drainage and bronchoaspiration should be used to avoid secretion retention. The syrup contains parahydroxybenzoates which can cause delayed allergic reactions and, more rarely, immediate reactions with bronchospasm and urticaria. The buccal tablets and sugar-free granules for oral solution contain sorbitol therefore patients with rare hereditary problems of fructose intolerance should not take this medicine. The buccal tablets and sugar-free granules for oral solution contain a source of phenylalanine which may be harmful in patients with phenylketonuria. The 100 mg and 200 mg granules for oral solution contain sunset yellow (E110) which can cause allergic reactions. The granules for oral solution contains sucrose therefore patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase isomaltase insufficiency should not take this medicine. The 200 mg granules for oral solution contains 2.2 g of sucrose per sachet while the 100 mg granules for oral solution contains 4.3 g of sucrose per sachet therefore it should be taken into consideration in patients suffering from diabetes mellitus. The tablets, the 150 ml syrup and the 200 ml syrup contain respectively 26.9, 16.6 and 17.3 mg of sodium, which must be taken into account in the case of patients with reduced kidney function or who follow a low-content diet. sodium.
PHARMACOTHERAPEUTIC CATEGORY
Expectorants, excluding associations with antitussives.
STORAGE
Sachets of 100 and 200 mg granules for oral solution, 200 mg granules for oral solution without sugar and 200 mg buccal tablets: store at a temperature not exceeding 30 degrees C.
CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity to the active substance or to any of the excipients and to other closely related substances from a chemical point of view; the drug is contraindicated in children younger than 2 years; generally contraindicated in pregnancy and lactation.
NAME
MUCOLITIC FLUIMUCIL
EXCIPIENTS
200 mg buccal tablets: anhydrous citric acid, sorbitol, mannitol, polyethylene glycol 6000, povidone, sodium bicarbonate, lemon flavor, mandarin flavor, aspartame, magnesium stearate, microcrystalline cellulose. Granules for oral solution without sugar 200 mg: sorbitol, aspartame, orange flavor. Granules for oral solution 200 mg: orange juice granules; Orange flavor; Saccharin; Sunset yellow (E 110); sucrose. Granules for oral solution 100 mg: orange juice granules; orange flavor; saccharin; sunset yellow (E 110); sucrose. Granules for oral solution without sugar 100 mg: sorbitol; aspartame; orange flavor. Syrup 100 mg / 5 ml 150 ml bottle: methyl parahydroxybenzoate, sodium benzoate, sodium edetate, sodium carboxymethylcellulose, raspberry flavor, sodium saccharinate, sodium hydroxide, purified water. Syrup 100 mg / 5 ml 200 ml bottle: methyl parahydroxybenzoate, sodium benzoate, sodium edetate, sodium carboxymethylcellulose, sodium cyclamate, sucralose, raspberry flavor, sodium saccharinate, sodium hydroxide, purified water.
SIDE EFFECTS
Below is a list of the frequency of adverse reactions that occurred after taking N-acetylcysteine by mouth. Disorders of the immune system. Uncommon: hypersensitivity '; very rare: anaphylactic shock, anaphylactic / anaphylactoid reaction. Nervous system disorders. Uncommon: headache. Ear and labyrinth disorders. Uncommon: tinnitus. Cardiac pathologies. Uncommon: tachycardia. Vascular pathologies. Very rare: haemorrhage. Respiratory, thoracic and mediastinal disorders. Rare: bronchospasm, dyspnoea; not known: bronchial obstruction. Gastrointestinal disorders. Uncommon: vomiting, diarrhea, stomatitis, abdominal pain, nausea; rare: dyspepsia. Skin and subcutaneous tissue disorders. Uncommon: urticaria, rash, angioedema, pruritus. General disorders and administration site conditions. Uncommon: pyrexia; not known: edema of the face. Diagnostic tests. Uncommon: low blood pressure. In very rare cases, severe skin reactions have occurred in temporal connection with the intake of N-acetylcysteine, such as Stevens-Johnson syndrome and Lyell syndrome. Although in most cases at least one other suspected drug more likely involved in the genesis of the aforementioned mucocutaneous syndromes has been identified, in case of mucocutaneous alterations it is advisable to contact your doctor and the intake of N-acetylcysteine must be stopped immediately. Some studies have confirmed a reduction in platelet aggregation when taking N-acetylcysteine. The clinical significance of these findings has not yet been defined.
PREGNANCY AND BREASTFEEDING
Even if the teratological studies conducted with the drug on animals did not show any teratogenic effect, however, as for the other drugs, its administration during pregnancy and during the lactation period, should be carried out only in case of actual need.
INDICATIONS
Treatment of respiratory diseases characterized by thick and viscous hypersecretion.
INTERACTIONS
Drug-Drug Interaction: Drug-drug interaction studies have only been conducted in adult patients. Antitussive drugs and N-acetylcysteine must not be taken at the same time as the reduction of the cough reflex could lead to an accumulation of bronchial secretions. Activated carbon can reduce the effect of N-acetylcysteine. It is recommended not to mix other drugs with the medicine solution. The information available on the antibiotic-N-acetylcysteine interaction refers to in vitro tests, in which the two substances were mixed, which showed a decreased activity of the antibiotic. However, as a precaution, it is recommended to take antibiotics by mouth at least two hours after the administration of N-acetylcysteine. It has been shown that the simultaneous intake of nitroglycerin and N-acetylcysteine causes significant hypotension and causes dilation of the temporal artery with possible onset of headache. If the simultaneous administration of nitroglycerin and N-acetylcysteine is necessary, it is necessary to monitor the patients for the appearance of hypotension which can 'also be severe and to alert them about the possible onset of headache. Drug-laboratory test interactions N-acetylcysteine can cause interference with the colorimetric assay method for the determination of salicylates. N-acetylcysteine can interfere with the test for the determination of ketones in urine.
DOSAGE
Adults: 1 sachet of 200 mg granules for oral solution (with or without sugar) or 2 sachets of 100 mg (with or without sugar) 2-3 times a day. 200 mg buccal tablets: 1 tablet 2-3 times a day Syrup 100 mg / 5 ml: 10 ml of syrup (1 scoop), equal to 200 mg of N-acetylcysteine, 2-3 times a day. Children older than 2 years: 100 mg granules for oral solution (with or without sugar): 1 sachet 2 to 4 times a day, according to age. Syrup 100 mg / 5 ml: half a scoop of syrup (5 ml), equal to 100 mg of N-acetylcysteine, 2 to 4 times a day according to age. The duration of therapy is from 5 to 10 days in the acute and chronic forms will be continued, in the opinion of the doctor, for periods of a few months. >> Method of administration. Granules for oral solution: dissolve the contents of one sachet in a glass containing a little water, stirring as needed with a teaspoon. In this way a pleasant solution is obtained which can be drunk directly from the glass or, in the case of small children, be given in teaspoons or in a bottle. The solution was taken as soon as it was ready. Buccal tablets: keep the tablet in the oral cavity until it is completely dissolved. Syrup: shake before use. Once opened, the syrup has a validity of 15 days.
ACTIVE PRINCIPLES
N-acetylcysteine.
034936118

Specific References

chat Comments (0)
No customer reviews for the moment.

Fluimucil Mucolytic Syrup...

€12.00 €10.80